Friday, 20 Jul 2018

You are here

29 September 2017 The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report discusses regulatory actions by NICE and FDA, higher death rates in RA and psoriasis, increased risk of RA with Asthma, rising numbers for OA, RA, and STDs.

  1. In RA, Smoking status recorded in 40%; cessation counseling in only 10% & was less likely when RA was controlled. https://buff.ly/2wWaHs2 
  2. ~1/3 RA pts rank their Disease activity higher than their Rheumatologist; more likely seronegative RA, those in LDAS with FM, Depression, high pain scores. https://buff.ly/2xygaK0 
  3. Higher MASEI (enthesitis) scores in PsA associated with more Joint damage, ankylosis, arthritis mutilans periostitis, axial Disease. https://buff.ly/2fU0k25 
  4. Review shows antiphopholipid Abs associated with and increased risk of idiopathic pulm arterial HTN, left-side valvular heart dz https://t.co/79KG9Qfb6k
  5. CDC: STDs new record high #s in 2016 - chlamydia (1.6mil), gonorrhea (470k) & syphilis (28k); more screening urged https://t.co/U6bsHAeWQa
  6. In Australia from 2015 to 2030, OA numbers are expected to increase 41%; RA by 37%, with cost of care rising by 37% for both. https://t.co/BNc2P4CyU3
  7. Mayo: 1996 to 2013, 58 cases of AAV in Olmstead Co - 23 GPA, 28 MPA & 7 EGPA. 60% MPO+, 30% PR3+: Prev 42.1/100,000 https://t.co/Q0n2Srmf7t
  8. Olmstead Co. Mayo Clinic study shows asthma significantly associated with increased risk of RA (adj OR 1.74) https://t.co/lcqkjGu9BK 
  9. Kevzara (sarilumab) has been recommended by UK NICE for use with MTX in adults with severe, active RA https://t.co/2fL8LDjLi3
  10. FDA Panel Backs New Zoster Subunit Vaccine
  11. Sirukumab Turned Down by FDA
  12.  Psoriasis Increases Risk of Major Adverse Cardiovascular Events  
  13. Increased Deaths in RA, Despite Decreasing Mortality Rates
  14. No Cancer Risk With Biologic Use
  15. The DownEaster Meeting – Westborough, MA  14 October 2017  
Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

The RheumNow Week in Review – Cocoon Therapy? (7.20.18)

Dr. Jack Cush reviews highlights from the news and social media on RheumNow.com in the past week. 

Proposed Changes for 2019 Medicare Fee Schedule

On July 12th the Centers for Medicare & Medicaid Services (CMS) released its proposed rule changes for the 2019 Medicare physician fee schedule.  This year, CMS has combined the Medicare physician fee schedule proposed rule with recommendations for the Quality Payment Program (QPP), which will be officially published in the Federal Register on July 27.

Trend Towards Fewer Self-Employed Physicians

 

A nationwide survey study analyzed healthcare provider (HCP) employment type (self-employed, employed by private sector, or employed by government) and annual labor earnings (2001 to 2015) and found that the health care landscape is changing with few self-employed practitioners and more being larger organizations. 

The RheumNow Week in Review –Fateful Outcomes in Rheumatology (7.13.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  Fateful outcomes in Rheumatology, what happens to Seronegatives, IL-23 fails, MRI progression, Not all inflammatory back pain becomes SpA:

The RheumNow Week in Review – Life Savers for Rheumatologists (6.29.18)

Dr. Jack Cush reviews selected news and journal reports from the past week on RheumNow.com.